U-Blot® Research Grade ImciromabCat. No. WA2968$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade ImciromabCat. No. WA2968
U-Blot® Research Grade ImaprelimabCat. No. WA2967
U-Blot® Research Grade ImalumabCat. No. WA2966
U-Blot® Research Grade IluzanebartCat. No. WA2965
U-Blot® Research Grade IladatuzumabCat. No. WA2964
U-Blot® Research Grade IgovomabCat. No. WA2963
U-Blot® Research Grade IfinatamabCat. No. WA2962
U-Blot® Research Grade IfabotuzumabCat. No. WA2961
U-Blot® Research Grade IeramilimabCat. No. WA2960
U-Blot® Research Grade IdarucizumabCat. No. WA2959
U-Blot® Research Grade IdactamabCat. No. WA2958
U-Blot® Research Grade IcrucumabCat. No. WA2957